MetLife Investment Management’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Hold |
0
| – | – | – | 2888 |
|
|
2024
Q2 | – | Sell |
-16,796
| Closed | -$51.2K | – | 2916 |
|
|
2024
Q1 | $51.2K | Sell |
16,796
-14,921
| -47% | -$45.5K | ﹤0.01% | 2713 |
|
|
2023
Q4 | $102K | Hold |
31,717
| – | – | ﹤0.01% | 2598 |
|
|
2023
Q3 | $122K | Hold |
31,717
| – | – | ﹤0.01% | 2478 |
|
|
2023
Q2 | $104K | Buy |
+31,717
| New | +$104K | ﹤0.01% | 2655 |
|
|
2020
Q4 | – | Sell |
-20,939
| Closed | -$120K | – | 2301 |
|
|
2020
Q3 | $120K | Hold |
20,939
| – | – | ﹤0.01% | 2129 |
|
|
2020
Q2 | $154K | Buy |
+20,939
| New | +$154K | ﹤0.01% | 2047 |
|